These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1039 related items for PubMed ID: 3079789

  • 1. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 2. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 3. Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis.
    Morris L, Troutt AB, Handman E, Kelso A.
    J Immunol; 1992 Oct 15; 149(8):2715-21. PubMed ID: 1357029
    [Abstract] [Full Text] [Related]

  • 4. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA.
    J Immunol; 1989 Jul 01; 143(1):266-74. PubMed ID: 2499629
    [Abstract] [Full Text] [Related]

  • 5. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
    Scott P.
    J Immunol; 1991 Nov 01; 147(9):3149-55. PubMed ID: 1833466
    [Abstract] [Full Text] [Related]

  • 6. Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-gamma to activate murine macrophages for killing of Leishmania major amastigotes.
    Bogdan C, Stenger S, Röllinghoff M, Solbach W.
    Eur J Immunol; 1991 Feb 01; 21(2):327-33. PubMed ID: 1900240
    [Abstract] [Full Text] [Related]

  • 7. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb 01; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 8. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS, Tarleton RL.
    J Immunol; 1991 May 15; 146(10):3591-8. PubMed ID: 1902857
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M.
    J Immunol; 1996 Jan 15; 156(2):644-52. PubMed ID: 8543816
    [Abstract] [Full Text] [Related]

  • 10. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA, Ogunremi O, Menon JN.
    Behring Inst Mitt; 1997 Feb 15; (98):153-9. PubMed ID: 9382736
    [Abstract] [Full Text] [Related]

  • 11. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 12. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM, Coffman RL.
    J Immunol; 1993 Jun 15; 150(12):5476-83. PubMed ID: 8515072
    [Abstract] [Full Text] [Related]

  • 13. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW, Rubin BY, Carriero S, Acosta AM.
    J Immunol; 1984 Oct 15; 133(4):2250-4. PubMed ID: 6432909
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S, Carrión J, Anderson C, Alonso C, Sacks D, Soto M.
    Infect Immun; 2005 Sep 15; 73(9):5842-52. PubMed ID: 16113303
    [Abstract] [Full Text] [Related]

  • 15. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug 15; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 16. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma.
    Cillari E, Dieli M, Maltese E, Milano S, Salerno A, Liew FY.
    J Immunol; 1989 Sep 15; 143(6):2001-5. PubMed ID: 2506273
    [Abstract] [Full Text] [Related]

  • 18. Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2.
    Solbach W, Lohoff M, Streck H, Rohwer P, Röllinghoff M.
    Immunology; 1987 Nov 15; 62(3):485-92. PubMed ID: 3499384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.